These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28737435)

  • 1. Investigation on influence of Wurster coating process parameters for the development of delayed release minitablets of Naproxen.
    Shah N; Mehta T; Aware R; Shetty V
    Drug Dev Ind Pharm; 2017 Dec; 43(12):1989-1998. PubMed ID: 28737435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of artificial neural networks for the selection of the most appropriate formulation and processing variables in order to predict the in vitro dissolution of sustained release minitablets.
    Leane MM; Cumming I; Corrigan OI
    AAPS PharmSciTech; 2003; 4(2):E26. PubMed ID: 12916908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of the coating process of minitablets in two different lab-scale fluid bed systems.
    Szczepanska M; Paduszynski P; Kotlowska H; Sznitowska M
    Drug Dev Ind Pharm; 2020 Jan; 46(1):31-41. PubMed ID: 31773983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of dissolution time and coating thickness of sustained release formulations using Raman spectroscopy and terahertz pulsed imaging.
    Müller J; Brock D; Knop K; Axel Zeitler J; Kleinebudde P
    Eur J Pharm Biopharm; 2012 Apr; 80(3):690-7. PubMed ID: 22245221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA; Faltinek J; Vaithiyalingam SR; Reddy IK; Khan MA
    Pharmazie; 2001 Apr; 56(4):321-4. PubMed ID: 11338673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the effect of coating equipment on tablet film quality using terahertz pulsed imaging.
    Haaser M; Naelapää K; Gordon KC; Pepper M; Rantanen J; Strachan CJ; Taday PF; Zeitler JA; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1095-102. PubMed ID: 23563103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the uniformity of coating thickness of pellets coated with a conventional Wurster chamber and a swirl generator-equipped Wurster chamber.
    Luštrik M; Dreu R; Šibanc R; Srčič S
    Pharm Dev Technol; 2012; 17(3):268-76. PubMed ID: 21073402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the coating process and
    Szczepanska M; Sznitowska M
    Pharmazie; 2019 Aug; 74(8):467-470. PubMed ID: 31526438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tablets and minitablets prepared from spray-dried SMEDDS containing naproxen.
    Čerpnjak K; Pobirk AZ; Vrečer F; Gašperlin M
    Int J Pharm; 2015 Nov; 495(1):336-346. PubMed ID: 26341323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of coating thickness of minitablets and pellets by dynamic image analysis.
    Czajkowska M; Sznitowska M; Kleinebudde P
    Int J Pharm; 2015 Nov; 495(1):347-353. PubMed ID: 26342248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for the preparation of sustained release-coated Metoprolol Succinate pellet-containing tablets.
    Yang Z; Yu J; Yang T; Xing H; Zhang J; Xian L; Ding P; Wang D
    Pharm Dev Technol; 2016 Dec; 21(8):943-950. PubMed ID: 26334840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
    Goole J; Vanderbist F; Amighi K
    Int J Pharm; 2007 Apr; 334(1-2):35-41. PubMed ID: 17097841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
    Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
    Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of quality by design approach in manufacturing process optimization of dry granulated, immediate release, coated tablets - a case study.
    Teżyk M; Jakubowska E; Milanowski B; Lulek J
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1626-1636. PubMed ID: 28481717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of cefuroxime axetil biphasic floating minitablets.
    Jammula S; Patra ChN; Swain S; Panigrahi KC; Nayak S; Dinda SC; Rao ME
    Drug Deliv; 2015 Jan; 22(1):125-35. PubMed ID: 24417642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
    Casas M; Aguilar-de-Leyva Á; Caraballo I
    Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the influence of coating methods on lipid spheres manufactured on rotor fluidized bed process.
    Gauthier P; Cardot JM; Beyssac E; Aiache JM
    Pharm Dev Technol; 2018 Jul; 23(6):655-662. PubMed ID: 28714756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bead layering as a process to stabilize nanosuspensions: influence of drug hydrophobicity on nanocrystal reagglomeration following in-vitro release from sugar beads.
    Kayaert P; Anné M; Van den Mooter G
    J Pharm Pharmacol; 2011 Nov; 63(11):1446-53. PubMed ID: 21988425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.